{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:04:58Z","timestamp":1792267498390,"version":"4.4.0"},"reference-count":81,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research at Jouf University","award":["DGSSR-2024-01-02052"],"award-info":[{"award-number":["DGSSR-2024-01-02052"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Fructose-driven metabolic disorders, such as obesity, non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and type 2 diabetes, are significant global health challenges. Ketohexokinase C (KHK-C), a key enzyme in fructose metabolism, is a promising therapeutic target. \u03b1-Mangostin, a naturally occurring prenylated xanthone, has been identified as an effective KHK-C inhibitor, prompting exploration of its analogs for enhanced efficacy. This study aimed to identify \u03b1-Mangostin analogs with improved inhibitory properties against KHK-C to address these disorders. Methods: A library of 1383 analogs was compiled from chemical databases and the literature. Molecular docking, binding free energy calculations, pharmacokinetic assessments, molecular dynamics simulations, and quantum mechani\u2013cal analyses were used to screen and evaluate the compounds. \u03b1-Mangostin\u2019s binding affinity (37.34 kcal\/mol) served as the benchmark. Results: Sixteen analogs demonstrated binding affinities superior to \u03b1-Mangostin (from \u221245.51 to \u221261.3 kcal\/mol), LY-3522348 (\u221245.36 kcal\/mol), and reported marine-derived inhibitors (from \u221222.74 to \u221251.83 kcal\/mol). Hits 7, 8, 9, 13, and 15 not only surpassed these benchmarks in binding affinity, but also exhibited superior pharmacokinetic properties compared to \u03b1-Mangostin, LY-3522348, and marine-derived inhibitors, indicating strong in vivo potential. Among these, hit 8 emerged as the best performer, achieving a binding free energy of \u221261.30 kcal\/mol, 100% predicted oral absorption, enhanced metabolic stability, and stable molecular dynamics. Conclusions: Hit 8 emerged as the most promising candidate due to its superior binding affinity, favorable pharmacokinetics, and stable interactions with KHK-C. These findings highlight its potential for treating fructose-driven metabolic disorders, warranting further experimental validation.<\/jats:p>","DOI":"10.3390\/ph18010126","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:04:12Z","timestamp":1737345852000},"page":"126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-7968","authenticated-orcid":false,"given":"Tilal","family":"Elsaman","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-6408","authenticated-orcid":false,"given":"Magdi Awadalla","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Giussani, M., Lieti, G., Orlando, A., Parati, G., and Genovesi, S. (2022). Fructose Intake, Hypertension and Cardiometabolic Risk Factors in Children and Adolescents: From Pathophysiology to Clinical Aspects. A Narrative Review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.792949"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-2-5","article-title":"Fructose, insulin resistance, and metabolic dyslipidemia","volume":"2","author":"Basciano","year":"2005","journal-title":"Nutr. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00394-016-1345-3","article-title":"Controversies about sugars: Results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes","volume":"55","author":"Khan","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3945\/ajcn.111.030205","article-title":"Soda consumption and the risk of stroke in men and women","volume":"95","author":"Bernstein","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Alturki, M.S. (2024). Exploring Marine-Derived Compounds: In Silico Discovery of Selective Ketohexokinase (KHK) Inhibitors for Metabolic Disease Therapy. Mar. Drugs, 22.","DOI":"10.3390\/md22100455"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.molmet.2021.101196","article-title":"Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction","volume":"48","author":"Gutierrez","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_7","first-page":"165","article-title":"WHO recommends reducing intake of\u2019free sugars\u2019 by adults and children","volume":"28","author":"Mohan","year":"2015","journal-title":"Natl. Med. J. India"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MOL.0000000000000043","article-title":"Nutrition, nonalcoholic fatty liver disease and the microbiome: Recent progress in the field","volume":"25","author":"Vos","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/joim.12632","article-title":"Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity","volume":"282","author":"Taskinen","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1017\/S0007114508968252","article-title":"Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women","volume":"100","author":"Swarbrick","year":"2008","journal-title":"Br. J. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2017.05.043","article-title":"Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity","volume":"153","author":"Schwarz","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2016.06.048","article-title":"Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome","volume":"253","author":"Gugliucci","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1119908109","article-title":"Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice","volume":"109","author":"Ishimoto","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ferreira, J.C., Villanueva, A.J., Fadl, S., Al Adem, K., Cinviz, Z.N., Nedyalkova, L., Cardoso, T.H., Andrade, M.E., Saksena, N.K., and Sensoy, O. (2024). Residues in the fructose-binding pocket are required for ketohexokinase-A activity. J. Biol. Chem., 300.","DOI":"10.1016\/j.jbc.2024.107538"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/acs.jmedchem.9b01701","article-title":"The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease","volume":"63","author":"Romero","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1369\/jhc.2009.953190","article-title":"Ketohexokinase: Expression and localization of the principal fructose-metabolizing enzyme","volume":"57","author":"Diggle","year":"2009","journal-title":"J. Histochem. Cytochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.26594","article-title":"High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase","volume":"58","author":"Ishimoto","year":"2013","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1021\/acs.jmedchem.7b00947","article-title":"Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)","volume":"60","author":"Huard","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1021\/acs.jmedchem.3c00715","article-title":"Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease","volume":"66","author":"Zhu","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_22","unstructured":"Durham, T. (2020). 2, 6-Diamino Pyridine Compounds. (WO2020051058 A), Patent."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1021\/acs.jmedchem.3c01410","article-title":"Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor","volume":"66","author":"Durham","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Heine, N., Weber, A., Pautsch, A., Gottschling, D., Uphues, I., Bauer, M., Ebenhoch, R., Magarkar, A., Nosse, B., and Kley, J.T. (2024). Discovery of BI-9787, a potent zwitterionic ketohexokinase inhibitor with oral bioavailability. Bioorg Med. Chem. Lett., 112.","DOI":"10.1016\/j.bmcl.2024.129930"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Le, M.T., Lanaspa, M.A., Cicerchi, C.M., Rana, J., Scholten, J.D., Hunter, B.L., Rivard, C.J., Randolph, R.K., and Johnson, R.J. (2016). Bioactivity-Guided Identification of Botanical Inhibitors of Ketohexokinase. PLoS ONE, 11.","DOI":"10.1055\/s-0035-1556298"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/ml200070g","article-title":"Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site","volume":"2","author":"Maryanoff","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dzobo, K. (2022). The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. Comprehensive Pharmacology, Elsevier.","DOI":"10.1016\/B978-0-12-820472-6.00041-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.freeradbiomed.2004.03.018","article-title":"Mechanism of cell death induced by an antioxidant extract of Cratoxylum cochinchinense (YCT) in Jurkat T cells: The role of reactive oxygen species and calcium","volume":"36","author":"Tang","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ptr.921","article-title":"Protective effect of Mangifera indica L. extract (Vimang\u00ae) on the injury associated with hepatic ischaemia reperfusion","volume":"17","author":"Giuliani","year":"2003","journal-title":"Phytother. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1016\/S0968-0896(02)00262-6","article-title":"Xanthones as inhibitors of microsomal lipid peroxidation and TNF-\u03b1 induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs)","volume":"10","author":"Madan","year":"2002","journal-title":"Bioorg Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.phytochem.2007.09.023","article-title":"Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen)","volume":"69","author":"Chin","year":"2008","journal-title":"Phytochemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4269\/ajtmh.2000.62.77","article-title":"Xanthones as antimalarial agents: Stage specificity","volume":"62","author":"Ignatushchenko","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.phymed.2003.09.012","article-title":"Antibacterial activity of \u03b1-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics","volume":"12","author":"Sakagami","year":"2005","journal-title":"Phytomedicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1573406416666200619114124","article-title":"Xanthone: A Promising Antimycobacterial Scaffold","volume":"17","author":"Elsaman","year":"2021","journal-title":"Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1248\/cpb.c12-00874","article-title":"Potent activity against multidrug-resistant Mycobacterium tuberculosis of \u03b1-mangostin analogs","volume":"61","author":"Sudta","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"ref_37","first-page":"578","article-title":"The importance of in-silico studies in drug discovery","volume":"2","author":"Roney","year":"2024","journal-title":"Intell. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","article-title":"COCONUT online: Collection of Open Natural Products database","volume":"13","author":"Sorokina","year":"2021","journal-title":"J. Cheminform."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_40","first-page":"9985604","article-title":"Novel \u03b1-Mangostin Derivatives from Mangosteen (Garcinia mangostana L.) Peel Extract with Antioxidant and Anticancer Potential","volume":"2021","author":"Tran","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1080\/14786419.2018.1510925","article-title":"Design, synthesis and cholinesterase inhibitory activity of alpha-mangostin derivatives","volume":"34","author":"Chi","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2020.11.018","article-title":"Prenylated xanthones from mangosteen (Garcinia mangostana) activate the AhR and Nrf2 pathways and protect intestinal barrier integrity in HT-29 cells","volume":"163","author":"Tocmo","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1007\/s00253-014-5947-5","article-title":"Efficient enzymatic systems for synthesis of novel alpha-mangostin glycosides exhibiting antibacterial activity against Gram-positive bacteria","volume":"98","author":"Le","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cmet.2020.05.012","article-title":"Deletion of fructokinase in the liver or in the intestine reveals differential effects on sugar-induced metabolic dysfunction","volume":"32","author":"Orlicky","year":"2020","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/ndt\/gfr223","article-title":"Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease","volume":"27","author":"Brymora","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100217","DOI":"10.1016\/j.jhepr.2020.100217","article-title":"Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis","volume":"3","author":"Shepherd","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a scientific workshop organized by the National Kidney Foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/adt.2023.060","article-title":"A review on molecular docking as an interpretative tool for molecular targets in disease management","volume":"22","author":"Sahu","year":"2024","journal-title":"Assay. Drug Dev. Technol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","article-title":"Use of molecular docking computational tools in drug discovery","volume":"60","author":"Stanzione","year":"2021","journal-title":"Prog. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/1062936X.2024.2415593","article-title":"Computational investigations of flavonoids as ALDH isoform inhibitors for treatment of cancer","volume":"35","author":"Mohamed","year":"2024","journal-title":"SAR QSAR Environ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Badiali, C., Petruccelli, V., Brasili, E., and Pasqua, G. (2023). Xanthones: Biosynthesis and Trafficking in Plants, Fungi and Lichens. Plants, 12.","DOI":"10.3390\/plants12040694"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., and Huang, Z. (2020). Computational Approaches in Preclinical Studies on Drug Discovery and Development. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.00726"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Madden, J.C. (2010). In silico approaches for predicting ADME properties. Recent Advances in QSAR Studies: Methods and Applications, Springer.","DOI":"10.1007\/978-1-4020-9783-6_10"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jung, W., Goo, S., Hwang, T., Lee, H., Kim, Y.K., Chae, J.W., Yun, H.Y., and Jung, S. (2024). Absorption Distribution Metabolism Excretion and Toxicity Property Prediction Utilizing a Pre-Trained Natural Language Processing Model and Its Applications in Early-Stage Drug Development. Pharmaceuticals, 17.","DOI":"10.3390\/ph17030382"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2193-9616-1-12","article-title":"In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin","volume":"1","author":"Lifongo","year":"2013","journal-title":"Silico Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/2193-1801-2-353","article-title":"An in silico evaluation of the ADMET profile of the StreptomeDB database","volume":"2","year":"2013","journal-title":"Springerplus"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Butnarasu, C., Garbero, O.V., Petrini, P., Visai, L., and Visentin, S. (2023). Permeability Assessment of a High-Throughput Mucosal Platform. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020380"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/092986709787002817","article-title":"Topological polar surface area: A useful descriptor in 2D-QSAR","volume":"16","author":"Prasanna","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Asano, D., Takakusa, H., and Nakai, D. (2023). Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010047"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wanat, K., Zydek, G., Hekner, A., and Brzezinska, E. (2021). In silico Plasma Protein Binding Studies of Selected Group of Drugs Using TLC and HPLC Retention Data. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030202"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wang, T., Sun, J., and Zhao, Q. (2023). Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism. Comput. Biol. Med., 153.","DOI":"10.1016\/j.compbiomed.2022.106464"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003088-200342060-00002","article-title":"Metabolic stability for drug discovery and development: Pharmacokinetic and biochemical challenges","volume":"42","author":"Masimirembwa","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/ar5001023","article-title":"Using quantum mechanical approaches to study biological systems","volume":"47","author":"Merz","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ginex, T., Vazquez, J., Estarellas, C., and Luque, F.J. (2024). Quantum mechanical-based strategies in drug discovery: Finding the pace to new challenges in drug design. Curr. Opin. Struct. Biol., 87.","DOI":"10.1016\/j.sbi.2024.102870"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1021\/jp0225774","article-title":"Ionization potential, electron affinity, electronegativity, hardness, and electron excitation energy: Molecular properties from density functional theory orbital energies","volume":"107","author":"Zhan","year":"2003","journal-title":"J. Phys. Chem. A"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lefi, N., Kazachenko, A.S., Raja, M., Issaoui, N., and Kazachenko, A.S. (2023). Molecular Structure, Spectral Analysis, Molecular Docking and Physicochemical Studies of 3-Bromo-2-hydroxypyridine Monomer and Dimer as Bromodomain Inhibitors. Molecules, 28.","DOI":"10.3390\/molecules28062669"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kumer, A., Chakma, U., Rana, M.M., Chandro, A., Akash, S., Elseehy, M.M., Albogami, S., and El-Shehawi, A.M. (2022). Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of alpha-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Molecules, 27.","DOI":"10.3390\/molecules27123694"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Adzhigirey","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_70","unstructured":"(2023). LigPrep, Schr\u00f6dinger, LLC. 2023-1."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/qsar.200730051","article-title":"Benchmarking the reliability of QikProp. Correlation between experimental and predicted values","volume":"27","author":"Ioakimidis","year":"2008","journal-title":"QSAR Comb. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Bowers, K.J., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., Klepeis, J.L., Kolossvary, I., Moraes, M.A., and Sacerdoti, F.D. (2006, January 11\u201317). Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, Tampa, FL, USA.","DOI":"10.1109\/SC.2006.54"},{"key":"ref_78","unstructured":"(2023). Maestro, Schr\u00f6dinger, LLC. 2023-1."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1080\/07391102.2023.2218936","article-title":"Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1: Molecular docking, ADMET, MM-GBSA calculations and molecular dynamics studies","volume":"42","author":"Elsaman","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1021\/jp901990u","article-title":"Isobaric\u2013isothermal molecular dynamics simulations utilizing density functional theory: An assessment of the structure and density of water at near-ambient conditions","volume":"113","author":"Schmidt","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Bouback, T.A., Pokhrel, S., Albeshri, A., Aljohani, A.M., Samad, A., Alam, R., Hossen, M.S., Al-Ghamdi, K., Talukder, M.E.K., and Ahammad, F. (2021). Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD. Molecules, 26.","DOI":"10.3390\/molecules26164961"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/1\/126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:31:29Z","timestamp":1759919489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/1\/126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ph18010126"],"URL":"https:\/\/doi.org\/10.3390\/ph18010126","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]}}}